KLF4


Journal

Acta neuropathologica communications
ISSN: 2051-5960
Titre abrégé: Acta Neuropathol Commun
Pays: England
ID NLM: 101610673

Informations de publication

Date de publication:
03 04 2020
Historique:
received: 14 01 2020
accepted: 09 03 2020
entrez: 5 4 2020
pubmed: 5 4 2020
medline: 16 1 2021
Statut: epublish

Résumé

Meningioma represents the most common primary brain tumor in adults. Recently several non-NF2 mutations in meningioma have been identified and correlated with certain pathological subtypes, locations and clinical observations. Alterations of cellular pathways due to these mutations, however, have largely remained elusive. Here we report that the Krueppel like factor 4 (KLF4)-K409Q mutation in skull base meningiomas triggers a distinct tumor phenotype. Transcriptomic analysis of 17 meningioma samples revealed that KLF4

Identifiants

pubmed: 32245394
doi: 10.1186/s40478-020-00912-x
pii: 10.1186/s40478-020-00912-x
pmc: PMC7118946
doi:

Substances chimiques

HIF1A protein, human 0
Hypoxia-Inducible Factor 1, alpha Subunit 0
KLF4 protein, human 0
Klf4 protein, mouse 0
Kruppel-Like Factor 4 0
Kruppel-Like Transcription Factors 0
Protein Kinase Inhibitors 0
temsirolimus 624KN6GM2T
Prolyl Hydroxylases EC 1.14.11.-
Mechanistic Target of Rapamycin Complex 1 EC 2.7.11.1
Sirolimus W36ZG6FT64

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

41

Subventions

Organisme : Deutsche Krebshilfe
ID : 70112956
Pays : International
Organisme : Deutsche Forschungsgemeinschaft
ID : MA2530/6-1
Pays : International

Références

Mol Cell. 2012 Jan 27;45(2):233-43
pubmed: 22284679
Nat Rev Cancer. 2011 Dec 15;12(1):9-22
pubmed: 22169972
Nat Genet. 1999 Aug;22(4):356-60
pubmed: 10431239
J Neurooncol. 2004 Dec;70(3):349-57
pubmed: 15662977
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Nat Rev Neurol. 2018 Feb;14(2):106-115
pubmed: 29302064
J Neurooncol. 2011 May;102(3):383-93
pubmed: 20803306
Nat Methods. 2015 Apr;12(4):357-60
pubmed: 25751142
Clin Cancer Res. 2013 Mar 1;19(5):1180-9
pubmed: 23406776
Nat Cell Biol. 2005 Nov;7(11):1074-82
pubmed: 16244670
Lancet Oncol. 2016 Sep;17(9):e383-91
pubmed: 27599143
Nucleic Acids Res. 2019 Jan 8;47(D1):D941-D947
pubmed: 30371878
Clin Cancer Res. 2007 Dec 15;13(24):7388-93
pubmed: 18094421
Bioinformatics. 2014 Apr 1;30(7):923-30
pubmed: 24227677
Neurosurgery. 1996 Jul;39(1):2-7; discussion 8-9
pubmed: 8805134
Cell Rep. 2019 Feb 26;26(9):2257-2265.e4
pubmed: 30811976
PLoS One. 2015 Jun 15;10(6):e0130341
pubmed: 26075898
Neuro Oncol. 2009 Dec;11(6):819-24
pubmed: 19066343
Acta Neurochir (Wien). 2013 Mar;155(3):407-13
pubmed: 23318687
Neuro Oncol. 2017 Aug 1;19(8):1088-1096
pubmed: 28482067
Breast Cancer Res Treat. 2008 Aug;110(3):465-75
pubmed: 17805961
Carcinogenesis. 2006 Jan;27(1):23-31
pubmed: 16219632
Therapy. 2011 Jul;8(4):359-367
pubmed: 21894244
Proc Natl Acad Sci U S A. 2006 Jan 3;103(1):105-10
pubmed: 16373502
J Neurol Neurosurg Psychiatry. 2010 May;81(5):502-5
pubmed: 19828483
Science. 2013 Mar 1;339(6123):1077-80
pubmed: 23348505
Oncogene. 2011 May 5;30(18):2161-72
pubmed: 21242971
Neuro Oncol. 2017 Nov 6;19(suppl_5):v1-v88
pubmed: 29117289
Neurosurgery. 1990 Sep;27(3):389-95; discussion 396
pubmed: 2234331
Genet Mol Res. 2011 Sep 23;10(3):2165-71
pubmed: 21968684
Cancer Cell. 2005 Aug;8(2):131-41
pubmed: 16098466
Acta Pharm Sin B. 2015 Sep;5(5):378-89
pubmed: 26579469
Neuro Oncol. 2017 Mar 1;19(3):345-351
pubmed: 28082415
J Biol Chem. 1996 Aug 16;271(33):20009-17
pubmed: 8702718
Neuropathol Appl Neurobiol. 2004 Jun;30(3):267-78
pubmed: 15175080
J Neurosurg. 2019 Oct 25;:1-10
pubmed: 31653806
Cell. 2007 Nov 30;131(5):861-72
pubmed: 18035408
Nature. 2009 Aug 6;460(7256):705-10
pubmed: 19578358
Acta Neuropathol. 2013 Mar;125(3):351-8
pubmed: 23404370
J Mol Cell Biol. 2017 Aug 1;9(4):315-324
pubmed: 28651379
Stem Cell Reports. 2017 Jun 6;8(6):1617-1629
pubmed: 28552603
Nat Protoc. 2006;1(2):581-5
pubmed: 17406285
Acta Biochim Biophys Sin (Shanghai). 2008 Jul;40(7):554-64
pubmed: 18604447

Auteurs

Niklas von Spreckelsen (N)

Department of Neuropathology, Otto-von-Guericke University, Magdeburg, Germany.
Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.
Department of Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.

Natalie Waldt (N)

Department of Neuropathology, Otto-von-Guericke University, Magdeburg, Germany.

Rebecca Poetschke (R)

Institute of Molecular Medicine, Martin Luther University, Halle/Saale, Germany.

Christoph Kesseler (C)

Department of Neuropathology, Otto-von-Guericke University, Magdeburg, Germany.

Hildegard Dohmen (H)

Department of Neuropathology, University Giessen, Giessen, Germany.

Hui-Ke Jiao (HK)

Department of Neuropathology, University Giessen, Giessen, Germany.

Attila Nemeth (A)

Department of Neuropathology, University Giessen, Giessen, Germany.

Stefan Schob (S)

Department of Neuroradiology, University Hospital Leipzig, Leipzig, Germany.

Cordula Scherlach (C)

Department of Neuroradiology, University Hospital Leipzig, Leipzig, Germany.

Ibrahim Erol Sandalcioglu (IE)

Department of Neurosurgery, Otto-von-Guericke University, Magdeburg, Germany.

Martina Deckert (M)

Department of Neuropathology, University Hospital Cologne, Cologne, Germany.

Frank Angenstein (F)

Laboratory for Non-invasive Imaging, DZNE, Magdeburg, Germany.

Boris Krischek (B)

Department of Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.

Pantelis Stavrinou (P)

Department of Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.

Marco Timmer (M)

Department of Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.

Marc Remke (M)

Pediatric Neuro-Oncology, Duesseldorf, Germany.

Elmar Kirches (E)

Department of Neuropathology, Otto-von-Guericke University, Magdeburg, Germany.

Roland Goldbrunner (R)

Department of Neurosurgery, Center for Neurosurgery, Faculty of Medicine and University Hospital, University of Cologne, Cologne, Germany.

E Antonio Chiocca (EA)

Department of Neurosurgery, Brigham and Women's Hospital, Harvard Medical School, Boston, USA.

Stefan Huettelmaier (S)

Institute of Molecular Medicine, Martin Luther University, Halle/Saale, Germany.

Till Acker (T)

Department of Neuropathology, University Giessen, Giessen, Germany.

Christian Mawrin (C)

Department of Neuropathology, Otto-von-Guericke University, Magdeburg, Germany. christian.mawrin@med.ovgu.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH